Viewing Study NCT06636838



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06636838
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-30

Brief Title: Language Matters Exploring the Impact of Language Concordance on Fertility Treatment Progression
Sponsor: None
Organization: None

Study Overview

Official Title: Language Matters Exploring the Impact of Language Concordance on Fertility Treatment Progression
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ImpaLa
Brief Summary: Currently patients presenting to the Fertility and Reproductive Medicine Center meet with an English-speaking provider and communicate through an interpreter as none of the physicians speak Spanish However this study PI is a native Spanish speaker and certified bilingual clinician Thus this study is looking to evaluate whether or not the use of an interpreter delays completion of testing and initiation of fertility treatment The medically indicated testing procedures and course of treatment will not be altered as a result of participation in the study Participants will be asked to complete a survey in their preferred language to gauge satisfaction and communication efficacy

This proposed study is significant as it seeks to address a critical gap in the understanding of how language concordance between healthcare providers and patients influences treatment outcomes in fertility care With Spanish being the most commonly spoken non-English language in the US evaluating the impact of Spanish language skills in medical care is both timely and essential This research will shed light on whether Spanish-speaking patients experience better treatment progression and outcomes when cared for by language-concordant providers versus when interpreters are used in fertility care

This prospective study will be conducted at Washington Universityamp39s Fertility Reproductive Medicine Center over a 12-month period The investigators aim to enroll a total of 70 Spanish-speaking patients based on previous patient trends at the Center 35 will be randomized to the intervention group being evaluated and treated by a Spanish-speaking provider and 35 will be randomized to standard of care communicating with an English-speaking provider through an interpreter
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None